Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cerliponase Alfa Observational Study

NCT04476862 is registered in ClinicalTrials.gov with BioMarin Pharmaceutical as lead sponsor.

NCT NCT04476862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04476862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cerliponase Alfa Observational Study
Lead sponsor
BioMarin Pharmaceutical
Phase
Observational
Overall status
Active, not recruiting
Start date
August 19, 2020
Completion date
August 31, 2030
Enrollment
35 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

late-infantile neuronal ceroid lipofuscinosis type 2